Combination and Optimal Sequencing of Systemic and Locoregional Therapies in Hepatocellular Carcinoma: Proceedings from the Society of Interventional Radiology Foundation Research Consensus PanelShow full item record

Title	Combination and Optimal Sequencing of Systemic and Locoregional Therapies in Hepatocellular Carcinoma: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel
Author	Thornton, Lindsay M.; Abi-Jaoudeh, Nadine; Lim, Howard J.; Malagari, Katerina; Spieler, Benjamin Oren; Kudo, Masatoshi; Finn, Richard S.; Lencioni, Riccardo; White, Sarah B.; Kokabi, Nima; Jeyarajah, D. Rohan; Chaudhury, Prosanto; Liu, David
Date	6/1/2024
Description	Hepatocellular carcinoma, historically, has had a poor prognosis with very few systemic options. Furthermore, most patients at diagnosis are not surgical candidates. Therefore, locoregional therapy (LRT) has been widely used, with strong data supporting its use. Over the last 15 years, there has been progress in the available systemic agents. This has led to the updated Barcelona Clinic Liver Cancer (BCLC) algorithm's inclusion of these new systemic agents, with advocacy of earlier usage in those who progress on LRT or have tumor characteristics that make them less likely to benefit from LRT. However, neither the adjunct of LRT nor the specific sequencing of combination therapies is addressed directly. This Research Consensus Panel sought to highlight research priorities pertaining to the combination and optimal sequencing of LRT and systemic therapy, assessing the greatest needs across BCLC stages.
Link	https://doi.org/10.1016/j.jvir.2024.02.017 https://repository.tcu.edu/handle/116099117/66010
Department	Burnett School of Medicine